Keith Flaherty's most recent trade in Kinnate Biopharma Inc was a trade of 25,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 12, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Kinnate Biopharma Inc | Keith Flaherty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2023 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
Kinnate Biopharma Inc | Keith Flaherty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2022 | 20,250 | 20,250 | - | - | Stock Option (right to buy) | |
Kinnate Biopharma Inc | Keith Flaherty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2021 | 20,250 | 20,250 | - | - | Stock Option (right to buy) |